PeptideDB

IL-17A antagonist 1 2205034-18-8

IL-17A antagonist 1 2205034-18-8

CAS No.: 2205034-18-8

IL-17A antagonist 1 (compound 1) is an IL-17A antagonist (inhibitor) with a Kd of 0.66 μM and IC50 of 1.14 μM.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

IL-17A antagonist 1 (compound 1) is an IL-17A antagonist (inhibitor) with a Kd of 0.66 μM and IC50 of 1.14 μM.

Physicochemical Properties


Molecular Formula C33H41FN6O4
Molecular Weight 604.71
Exact Mass 604.317
CAS # 2205034-18-8
Appearance White to off-white solid powder
Density 1.3±0.1 g/cm3
Boiling Point 914.1±65.0 °C at 760 mmHg
Flash Point 506.6±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.610
LogP 1.5
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets IL-17A 1.14 nM (IC50) IL-17A 0.66 μM (Kd)
References

[1]. Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep. 2016 Aug 16;6:30859.


Solubility Data


Solubility (In Vitro) DMSO: 41.67 mg/mL (68.91 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (4.13 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (3.44 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (3.44 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.6537 mL 8.2684 mL 16.5369 mL
5 mM 0.3307 mL 1.6537 mL 3.3074 mL
10 mM 0.1654 mL 0.8268 mL 1.6537 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.